COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 2131: Articles 21301-21310  | Next

Cost and social distancing dynamics in a mathematical model of COVID-19 with application to Ontario, Canada
Moyles, I. R., Heffernan, J. M., Kong, J. D.
10.1101/2020.10.21.20217158 — Posted: 2020-10-25
Mortality among Adults Ages 25-44 in the United States During the COVID-19 Pandemic.
Faust, J. S., Krumholz, H., Dickerson, K. L., Lin, Z., Gilman, C., Walensky, R. P.
10.1101/2020.10.21.20217174 — Posted: 2020-10-25
SARS-CoV-2 surveillance in untreated wastewater: first detection in a low-resource community in Buenos Aires, Argentina.
Iglesias, N. G., Gebhard, L. G., Carballeda, J. M., Aiello, I., Recalde, E., Terny, G., Ambrosolio, S., L'Arco, G., Konfino, J., Brardinelli, J. I.
10.1101/2020.10.21.20215434 — Posted: 2020-10-25
COVID-19 in regions with low prevalence and low density of population. An uncertainty dynamic modeling approach.
Garrido, J. M., Martinez-Rodriguez, D., Rodriguez-Serrano, F., Diez-Domingo, J., Villanueva, R. J.
10.1101/2020.10.21.20215418 — Posted: 2020-10-25
Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: a cohort study in a SARS-CoV-2 testing center on Reunion island
Joubert, A., Andry, F., Bertolotti, A., Accot, F., Koumar, Y., Legrand, F., Poubeau, P., Manaquin, R., Gerardin, P., Levin, C.
10.1101/2020.10.20.20214718 — Posted: 2020-10-25 Discussion: Onsite
Risk Factors Associated with Increased Antibiotic Use in COVID-19 Hospitalized Patients
Martin, A. J., Pillinger, K. E., Shulder, S., Quartuccio, K., Dobrzynski, D.
10.1101/2020.10.21.20217117 — Posted: 2020-10-25
The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy
Mohamud, Y., Chao Xue, Y., Liu, H., Seng Ng, C., Bahreyni, A., Jan, E., Luo, H.
10.1101/2020.10.23.353219 — Posted: 2020-10-25
Evidence for ZAP-independent CpG reduction in SARS-CoV-2 genome, and pangolin coronavirus origin of 5'UTR
Afrasiabi, A., Alinejad-Rokny, H., Lovell, N., Xu, Z., Ebrahimi, D.
10.1101/2020.10.23.351353 — Posted: 2020-10-24
SARS-CoV-2 RBD mutations, ACE2 genetic polymorphism, and stability of the virus-receptor complex: The COVID-19 host-pathogen nexus.
Ashoor, D., Ben Khalaf, N., Marzouq, M., Jarjanazi, H., Fathallah, M. D.
10.1101/2020.10.23.352344 — Posted: 2020-10-24
Ivermectin repurposing for COVID-19 therapy: Safety and pharmacokinetic assessment of a novel nasal spray formulation in a pig model
Errecalde, J., Lifschitz, A., Vecchioli, G., Ceballos, L., Errecalde, F., Ballent, M., Marin, G., Daniele, M., Turic, E., Spitzer, E., Toneguzzo, F., Gold, S., Krolewiecki, A., Alvarez, L., Lanusse, C.
10.1101/2020.10.23.352831 — Posted: 2020-10-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).